Search research articles
Contact Us
Filters
Showing results (271-280 of 299) with videos related to
Page
of 30
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report
Chris Davis, Tom Tipton, Suleman Sabir, et al.
Cell
|
July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell
|
September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Nature Communications
|
July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Anahita Fathi, Christine Dahlke, Verena Krähling, et al.
Scientific Reports
|
November 10, 2019
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Nature Microbiology
|
March 26, 2024
Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
Rüdiger Groß, Hanna Reßin, Pascal von Maltitz, et al.
Journal of Virology
|
September 16, 2024
Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive network
Nina Hofmann, Marek Bartkuhn, Stephan Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2021
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, et al.
The New England Journal of Medicine
|
April 12, 2003
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Christian Drosten, Stephan Günther, Wolfgang Preiser, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 299) with videos related to
Sort By:
Page
of 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report
Chris Davis, Tom Tipton, Suleman Sabir, et al.
Cell
|
July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Cell
|
September 18, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer, Matthias Zehner, Timm Weber, et al.
Nature Communications
|
July 19, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
Anahita Fathi, Christine Dahlke, Verena Krähling, et al.
Scientific Reports
|
November 10, 2019
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Nature Microbiology
|
March 26, 2024
Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
Rüdiger Groß, Hanna Reßin, Pascal von Maltitz, et al.
Journal of Virology
|
September 16, 2024
Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive network
Nina Hofmann, Marek Bartkuhn, Stephan Becker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 2021
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde, et al.
The New England Journal of Medicine
|
April 12, 2003
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Christian Drosten, Stephan Günther, Wolfgang Preiser, et al.
The Lancet. Infectious Diseases
|
April 24, 2020
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
Page
of 30